Wanting to take advantage of the recent selloff in pockets of the share market?
Well, Bell Potter thinks the three ASX 200 shares in this article could be in the buy zone after heavy declines. Here's what it is recommending:
Image source: Getty Images
Light & Wonder Inc (ASX: LNW)
Bell Potter continues to rate this gaming technology company as an ASX 200 share to buy.
It highlights that the company has a compelling growth-at-a-reasonable price (GARP) profile relative to peers. It said:
We rate LNW a Buy due to a compelling GARP profile relative to the ASX 100 and ALL (15% discount to EV / EBITA). We expect a continuation in the re-rate observed since the ASX sole listing in November 2025, as long as the company executes on market share gains in its respective markets. We believe LNW's heightened investment in R&D will drive continued growth, particularly in the Premium leased market.
Bell Potter has retained its buy rating with an improved price target of $230.00 (from $176.00).
Pro Medicus Ltd (ASX: PME)
Another ASX 200 share that Bell Potter rates highly is health imaging technology company Pro Medicus.
Although it fell a touch short with its half-year results, it remains positive and is recommending investors buy the dip. It said:
The ongoing implementation of several major projects is expected to conclude by October 2026 inclusive of an estimated $29m boost to annual recurring revenues from the very large Trinity contract. For this reason we remain confident regarding the ongoing outlook for revenue and earnings growth. Target price is reduced by 25% to $240 following this downgrade and the re-rating now applied to software providers. Retain Buy rating. We believe the current price is an attractive entry point.
Bell Potter has retained its buy rating with a reduced price target of $240.00 (from $320.00).
Temple & Webster Group Ltd (ASX: TPW)
Finally, this online furniture and homewares retailer's shares are being tipped as a buy.
Although its time as an ASX 200 share could be limited, the broker remains positive. It said:
Our views are unchanged of TPW's ability to outperform over the long term as market share capture in an expanded TAM is expedited with range, pricing/scale advantages, AI/data capability backed by a strong balance sheet (~$160m cash). Trading at ~1.2x EV/Sales post today's correction in the share price, we see TPW reverting back to valuation levels in Oct-23 at which time the company was growing revenue at sub20% and see some downside risk priced in the name, however potential for removal from the S&P/ASX 200 Index at the next rebalance in March remains.
Bell Potter now has a buy rating and $13.00 price target (from $19.50) on its shares.
